Navigation Links
Patent Attorney John Rizvi Speaks at FIME International Medical Expo

The FIME 2009 International Medical Expo is the largest and most comprehensive medical exposition of its kind. John Rizvi will deliver a presentation titled, "Preservation of Legal Rights in Medical Innovations" at the FIME 2009 International Medical Expo in Miami Beach.

Miami, FL (PRWEB) August 5, 2009 -- On August 13, 2009 at 1:00 PM, attorney John Rizvi will deliver a presentation titled, "Preservation of Legal Rights in Medical Innovations" at the FIME 2009 International Medical Expo in Miami Beach.

Florida has one of the country's largest medical device sectors. Florida ranks second in the U.S. for number of FDA-registered medical device establishments, according to the FDA (2007). Over 20,000 Floridians work in this sector.

The FIME 2009 International Medical Expo is the largest and most comprehensive medical exposition of its kind. The exposition will feature medical manufacturers from around the world. It is held at the Miami Beach Convention Center, with over 500,000 square feet of exhibitor space. The four types of featured attendees are medical equipment, medical products, medical services and medical technology companies.

South Florida has seen steady growth in the medical device industry over the past ten years and John Rizvi, a patent attorney who specializes in patenting medical devices, is giving a presentation to educate medical technology companies on the importance of patenting new inventions.

"Patents help eliminate competition by giving patent holders the right to prevent anyone else from making, using, selling, or importing competing products in their market. This allows a patent holder to maintain monopoly pricing and avoids the product becoming a commodity," said Rizvi.

Patents for medical device companies have become increasingly important as more competitors from overseas and nationally are launching knock-off products based on a patent holder's intellectual property.

John Rizvi said that he often sees companies work with attorneys who don't fully understand the medical patent industry and draft claims that are too narrow in scope. This can allow a competitor to "design around" a patented product.

John Rizvi has over 14 years of experience focused exclusively on the preparation and prosecution of U.S. and international patent and trademark applications, patent and trademark validity and infringement opinions, licensing, transactional support, and all aspects of intellectual property litigation. John is an Adjunct Professor at the Nova Southeastern University Shepard Board Law Center where he teaches courses in intellectual property law.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. Pressure BioSciences, Inc. Issued First Patent in Canada
4. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
5. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
8. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
9. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
10. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
11. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
Post Your Comments:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology:
(Date:4/28/2016)... and BANGALORE, India , April ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... today announced a global partnership that will provide ... to use mobile banking and payment services.      ... a key innovation area for financial services, but it also ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
Breaking Biology News(10 mins):